...
首页> 外文期刊>Virology Journal >Characteristics of oseltamivir-resistant influenza A (H1N1) pdm09 virus during the 2013–2014 influenza season in Mainland China
【24h】

Characteristics of oseltamivir-resistant influenza A (H1N1) pdm09 virus during the 2013–2014 influenza season in Mainland China

机译:2013-2014年中国大陆流感季节耐奥司他韦的甲型H1N1流感pdm09病毒的特征

获取原文

摘要

Background In this study, we analyzed the characteristics of oseltamivir-resistant influenza A (H1N1) pdm09 virus isolated from patients in mainland China during the influenza season from September 2013 through March 2014, and provide guidance on which antiviral to be used for clinical treatment. Methods The all viruses collected from September 1, 2013 through March 31, 2014 were obtained from the Chinese National Influenza Surveillance Network. A fluorescence-based assay was used to detect virus sensitivity to neuraminidase inhibitors (NAIs). The hemagglutinin (HA) and neuraminidase (NA) gene of the oseltamivir-resistant viruses were sequenced. Results A total of 24 (2.14?%) influenza A (H1N1) pdm09 viruses that were resistant to oseltamivir were identified. These 24 viruses were isolated from 23 patients and no epidemiological link among them could be identified. Except for one virus with the H275H/Y mixture substitution, all the other 23 viruses had H275Y substitution in the NA protein. Sequence analysis revealed that the amino acid substitutions in the HA protein of influenza A (H1N1) pdm09 viruses with H275Y substitution isolated from mainland China were similar to the viruses from clustered cases reported in the United States, and the amino acid substitutions in the NA protein were similar to the viruses reported in Sapporo, Japan in 2013–2014. All of the oseltamivir-resistant viruses in mainland China and Japan possessed additional substitutions N386K, V241I and N369K in the NA protein, while most (>89?%) resistant-viruses from the United States during the same period possess V241I and N369K and did not have the N386K substitution. The N386K substitution was also exist in most sensitive viruses during the same period in mainland China. The amino acid substitutions in both HA and NA protein differed from the clustered cases from Australia reported in 2011 with additional substitutions. The drug-resistant influenza A(H1N1) pdm09 viruses were from patients without any known NAIs medication history prior to sampling. Conclusions During the influenza season from September 2013 through March 2014 in Mainland China, oseltamivir-resistant influenza A(H1N1)pdm09 viruses were much more frequently detected than ever since the appearance of the virus in 2009.
机译:背景技术在本研究中,我们分析了2013年9月至2014年3月流感季节从中国大陆患者中分离出的耐奥司他韦A型流感(H1N1)pdm09病毒的特征,并提供了针对哪种抗病毒药物进行临床治疗的指南。方法2013年9月1日至2014年3月31日收集的所有病毒均来自中国国家流感监测网络。基于荧光的分析用于检测病毒对神经氨酸酶抑制剂(NAIs)的敏感性。对耐奥司他韦病毒的血凝素(HA)和神经氨酸酶(NA)基因进行了测序。结果共鉴定出24株对奥司他韦具有抗药性的A(H1N1)流感pdm09病毒(2.14%)。从23例患者中分离出这24种病毒,尚无法确定它们之间的流行病学联系。除了一种具有H275H / Y混合物替代的病毒外,所有其他23种病毒在NA蛋白中均具有H275Y替代。序列分析表明,从中国大陆分离到的具有H275Y替换的甲型流感(H1N1)pdm09病毒的HA蛋白中的氨基酸替换与美国报道的成簇病例的病毒相似,而NA蛋白中的氨基酸替换与2013-2014年日本札幌报道的病毒相似。中国大陆和日本的所有耐奥司他韦的病毒在NA蛋白中均具有N386K,V241I和N369K的其他取代,而同期来自美国的大多数(> 89 %%)抗性病毒都具有V241I和N369K,并且没有N386K替代。在同一时期,中国大陆大多数敏感病毒中也存在N386K替代。 HA和NA蛋白中的氨基酸替换均不同于澳大利亚在2011年报道的簇状病例,但有其他替换。耐药甲型H1N1流感pdm09病毒来自没有任何已知NAI药物治疗史的患者。结论在2013年9月至2014年3月的中国大陆流感季节,自2009年出现以来,耐奥司他韦A(H1N1)pdm09流感病毒的频率比以往任何时候都要高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号